BOUT Stock Price Prediction

The radar chart shows that buying Innovator IBD Breakout Opportunities ETF (BOUT) stock in July has the highest probability of a positive return (87.50%), while September has the lowest probability (22.22%).

BOUT's stock price rose by 20.79% in 2024,decreased by -7.83% in 2025, and went up by 9.62%in 2026.

No bullish technical signals identified.

No bearish technical signals identified.

BOUT has 0 buy signals and 0 sell signals now. Overall the technical rating for BOUT is Neutral. Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BOUT

Innovator IBD Breakout Opportunities ETF's overall moving average trend leans more bullish as of March 04 2026, with 0 negative signals and 4 positive signal.

The price prediction chart for Innovator IBD Breakout Opportunities ETF (BOUT) stock, as of Invalid Date, forecasts a %% change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

In , Innovator IBD Breakout Opportunities ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.

In , Innovator IBD Breakout Opportunities ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.